DSM Biologics, a business unit of DSM Pharmaceutical Products, is a global
provider of manufacturing technology & services to the biopharmaceutical
industry. In addition to offering world-class biopharmaceutical manufacturing
services, DSM Biologics has co-exclusive rights, along with Dutch biotech
company Crucell N.V., to license the high-producing PER.C6® human cell line as
a production platform for recombinant proteins and monoclonal antibodies. DSM
Biologics’ FDA-approved facility in Groningen, The Netherlands was established
in 1986, and has a strong track record in using a broad range of cell lines
(PER.C6®, CHO, hybridoma, etc.) in biopharmaceutical manufacturing, and has
wide-range of experience using multiple manufacturing (batch, fed-batch and
continuous perfusion) and purification techniques. The combination of the
PER.C6® human cell line and DSM’s manufacturing services provides companies
with a turn-key biologic manufacturing solution reducing cost, risk and time
to market.
.gif)
